126 results
Page 3 of 7
8-K
EX-10.3
c8izdtd1gfw5ls w056
20 Mar 19
Entry into a Material Definitive Agreement
1:47pm
8-K
EX-10.1
5m3eszp62xggr
20 Mar 19
Entry into a Material Definitive Agreement
1:47pm
8-K
EX-10.2
8u6u2t6890791os8
20 Mar 19
Entry into a Material Definitive Agreement
1:47pm
S-1
EX-10.25
9gw qdq44dec0iqb6db
6 Feb 19
IPO registration
5:21pm
8-K
EX-10.1
mjd9rbey4cnpiom6g1s
6 Jun 18
Departure of Directors or Certain Officers
5:28pm
8-K
EX-10.1
5xy4ll vzgej
20 Feb 18
Combined Company Renamed Vaxart, Inc. and Will Begin Trading
12:00am
8-K
EX-10.3
gutwde
20 Feb 18
Combined Company Renamed Vaxart, Inc. and Will Begin Trading
12:00am
8-K
EX-10.2
fvp6ghqt0u3wz6dg kt
20 Feb 18
Combined Company Renamed Vaxart, Inc. and Will Begin Trading
12:00am
8-K
EX-10.1
674p 5y9g9jib
9 Feb 18
Aviragen Adjourns Special Meeting of Stockholders to Allow Stockholders to Consider Improved Merger Deal Terms
12:00am
425
EX-10.1
h77xf5e
9 Feb 18
Business combination disclosure
12:00am